1. Home
  2. CMT vs MCRB Comparison

CMT vs MCRB Comparison

Compare CMT & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMT
  • MCRB
  • Stock Information
  • Founded
  • CMT 1996
  • MCRB 2010
  • Country
  • CMT United States
  • MCRB United States
  • Employees
  • CMT N/A
  • MCRB N/A
  • Industry
  • CMT Electronic Components
  • MCRB Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMT Consumer Discretionary
  • MCRB Health Care
  • Exchange
  • CMT Nasdaq
  • MCRB Nasdaq
  • Market Cap
  • CMT 129.5M
  • MCRB 141.9M
  • IPO Year
  • CMT N/A
  • MCRB 2015
  • Fundamental
  • Price
  • CMT $15.64
  • MCRB $0.68
  • Analyst Decision
  • CMT Strong Buy
  • MCRB Hold
  • Analyst Count
  • CMT 1
  • MCRB 5
  • Target Price
  • CMT $27.00
  • MCRB $4.00
  • AVG Volume (30 Days)
  • CMT 41.0K
  • MCRB 787.5K
  • Earning Date
  • CMT 05-06-2025
  • MCRB 03-13-2025
  • Dividend Yield
  • CMT N/A
  • MCRB N/A
  • EPS Growth
  • CMT N/A
  • MCRB N/A
  • EPS
  • CMT 1.51
  • MCRB 0.00
  • Revenue
  • CMT $302,378,000.00
  • MCRB N/A
  • Revenue This Year
  • CMT N/A
  • MCRB N/A
  • Revenue Next Year
  • CMT N/A
  • MCRB N/A
  • P/E Ratio
  • CMT $10.38
  • MCRB $772.80
  • Revenue Growth
  • CMT N/A
  • MCRB N/A
  • 52 Week Low
  • CMT $12.25
  • MCRB $0.54
  • 52 Week High
  • CMT $21.00
  • MCRB $1.53
  • Technical
  • Relative Strength Index (RSI)
  • CMT 69.16
  • MCRB 41.45
  • Support Level
  • CMT $14.48
  • MCRB $0.69
  • Resistance Level
  • CMT $15.29
  • MCRB $0.76
  • Average True Range (ATR)
  • CMT 0.45
  • MCRB 0.05
  • MACD
  • CMT 0.15
  • MCRB -0.00
  • Stochastic Oscillator
  • CMT 96.20
  • MCRB 29.07

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Share on Social Networks: